Updated Jul 16, 2026
Strobeck Mark has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $29K.
Mark Strobeck is the President and CEO of Rockwell Medical, Inc., a company specializing in hemodialysis products. He has held various roles within the company, including Director, and has been involved in its operations and strategic direction.
| Role | President and CEO, Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | RMTI | ROCKWELL MEDICAL, INC. | A — Grant or award | 30.0K | $0.00 | |
| 2026-03-16 | RMTI | ROCKWELL MEDICAL, INC. | F — Tax withholding / forfeiture | 7.3K | $0.90 | $7K |
| 2025-10-01 | RMTI | ROCKWELL MEDICAL, INC. | S — Open-market sale | 6.9K | $1.19 | $8K |
| 2025-07-01 | RMTI | ROCKWELL MEDICAL, INC. | S — Open-market sale | 6.9K | $0.82 | $6K |
| 2025-05-20 | RMTI | ROCKWELL MEDICAL, INC. | A — Grant or award | 220.0K | $0.00 | |
| 2025-04-01 | RMTI | ROCKWELL MEDICAL, INC. | S — Open-market sale | 6.9K | $1.08 | $7K |
| 2024-10-02 | RMTI | ROCKWELL MEDICAL, INC. | S — Open-market sale [10b5-1] | 2.2K | $3.69 | $8K |
Mark Strobeck is the President and CEO of Rockwell Medical, Inc., a company specializing in hemodialysis products. He has held various roles within the company, including Director, and has been involved in its operations and strategic direction.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($29K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Strobeck Mark profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.